Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Scientists at State University of New York report research in breast cancer
April 16th, 2009
According to a study from the United States, "HER2 gene amplification by fluorescence in Situ hybridization and protein expression by immunohistochemistry (IHC) have been used for prognosis and guiding treatment of invasive ductal carcinoma of the breast with trastuzumab. Accurate evaluation of HER2 status is important in file management of patients with candidacy for the HER2-targeting therapy." "Despite previous studies., effects of polysomy of chromosome 17, at which HER2 is located, oil HER2 protein expression remains controversial. In this study, we calculated the average copy numbers of HER2 and chromosome 17 (CEP17) per nucleus in 109 cases of invasive breast...
Source: Women's Health Weekly (2009-04-16)
|
